Retrospective Cohort Analysis of 1-Hour Infliximab Infusions in Pediatric Patients
This study showcases that 1-hour infliximab infusions are well-tolerated and appear safe in pediatric patients.
Authors
- Arun George (ORCID: https://orcid.org/0000-0002-1690-0359)
- Drew Goodrich
- R Kozioł
- Jennifer Stein (ORCID: https://orcid.org/0000-0002-0962-4982)
- Brienne Costigan
Institutions
- Tufts Medical Center (US)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.5863/1551-6776-30.1.65
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00